ITGB3 and cancer: CT26 cancer cell-bearing mice were treated with exosomes secreted by ITGB3 overexpressing SW480-ITGB3 LV cells and its control cell line SW480-CON LV at 50-μg protein weight per dose for each mouse every other day from day 1 to day 21 (Fig. 7C).